Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Yubo International Biotech Ltd

Get SEC filing alerts via email and in your feed for Yubo International Biotech Ltd

YBGJ

Yubo International Biotech Ltd

About Yubo International Biotech Ltd

Yubo International Biotech Limited is a U.S.-based holding company focused on biotechnology, primarily operating through its subsidiaries in China. It develops and commercializes stem cell storage, healthcare, and personal care products, leveraging proprietary stem cell technology. The company emphasizes research, product development, and building a stem cell bank, serving health management, anti-aging, and regenerative medicine markets with a competitive edge in endometrial stem cell applications.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from Yubo International Biotech Ltd

1
1
Yubo International Biotech Ltd Yubo International Biotech Reports Decreased Net Loss and Ongoing Financial Challenges

Via official filing (AI summary) | 23 days ago | 0 comments

2
1
Yubo International Biotech Ltd Yubo International Biotech Reports 256% Revenue Increase to $12.4 Million for Fiscal Year 2025

Via official filing (AI summary) | 2 months ago | 0 comments

3
1
Yubo International Biotech Ltd Yubo International Biotech Reports Q3 2025 Financial Results with Reduced Net Loss

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
Yubo International Biotech Ltd Yubo International Biotech Reports Decreased Net Loss and No Revenue in Q2 2025

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
Yubo International Biotech Ltd Yubo International Biotech Reports Zero Revenue and Increased Losses in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
Yubo International Biotech Ltd Yubo International Biotech Reports Significant Revenue Decline and Increased Losses for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
Yubo International Biotech Ltd Yubo International Biotech Reports Significant Financial Challenges, Net Loss of $621,053 in Latest Quarter

Via official filing (AI summary) | over 1 year ago | 0 comments